References
- Whitton JL, Cornell CT, Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol 2005;3:765–76
- Wu KX, Ng MM-L, Chu JJH. Developments towards antiviral therapies against enterovirus 71. Drug Discov Today 2010;15:1041–51
- McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002;26:91–107
- Rhoades RE, Tabor-Godwin JM, Tsueng G, Feuer R. Enterovirus infections of the central nervous system. Virology 2011;411:288–305
- Yang F, Ren L, Xiong Z, et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 2009;47:2351–2
- Shang L, Xu M, Yin Z. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res 2013;97:183–94
- Norder H, De Palma AM, Selisko B, et al. Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antiviral Res 2011;89:204–18
- Kuo CJ, Shie JJ, Fang JM, et al. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem 2008;16:7388–98
- Lu G, Qi J, Chen Z, et al. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. J Virol 2011;85:10319–31
- Wang J, Fan T, Yao X, et al. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J Virol 2011;85:10021–30
- Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967;27:157–62
- Binford SL, Maldonado F, Brothers MA, et al. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother 2005;49:619–26
- Matthews DA, Dragovich PS, Webber SE, et al. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci USA 1999;96:11000–7
- Patick AK, Binford SL, Brothers MA, et al. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 1999;43:2444–50
- Patick AK. Rhinovirus chemotherapy. Antiviral Res 2006;71:391–6
- Zhang X, Song Z, Qin B, et al. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. Antiviral Res 2013;97:264–9
- Wang QM, Johnson RB, Cox GA, et al. A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. Anal Biochem 1997;252:238–45
- Poulie CBM, Bunch L. Heterocycles as nonclassical bioisosteres of α-amino acids. ChemMedChem 2013;8:205–15
- Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B 2001;105:6474–87
- Polak E, Ribière G. Note on the convergence of methods of conjugate directions. Recherche opérationelle, Série Rouge 1969;16:35–43
- Hasel W, Hendrickson TF, Still WC. A rapid approximation to the solvent accessible surface areas of atoms. Tetrahedron Comput Methodol 1988;1:103–16